ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
44.43 USD
+0.36 (+0.82%)
Taking everything into account, AORT scores 5 out of 10 in our fundamental rating. AORT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
AORT had a positive operating cash flow in the past year.
AORT had negative earnings in each of the past 5 years.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.06%, AORT is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
AORT has a Return On Equity of -2.08%. This is in the better half of the industry: AORT outperforms 71.66% of its industry peers.
AORT has a better Return On Invested Capital (2.28%) than 69.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT's Operating Margin of 5.26% is fine compared to the rest of the industry. AORT outperforms 70.59% of its industry peers.
AORT's Operating Margin has improved in the last couple of years.
AORT's Gross Margin of 64.50% is fine compared to the rest of the industry. AORT outperforms 65.78% of its industry peers.
AORT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AORT has more shares outstanding
Compared to 5 years ago, AORT has more shares outstanding
Compared to 1 year ago, AORT has a worse debt to assets ratio.
2.2 Solvency
AORT has an Altman-Z score of 3.83. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
AORT has a better Altman-Z score (3.83) than 74.33% of its industry peers.
The Debt to FCF ratio of AORT is 12.48, which is on the high side as it means it would take AORT, 12.48 years of fcf income to pay off all of its debts.
AORT has a better Debt to FCF ratio (12.48) than 72.19% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that AORT is not too dependend on debt financing.
AORT has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 3.83 |
ROIC/WACC0.27
WACC8.44%
2.3 Liquidity
AORT has a Current Ratio of 3.93. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a better Current ratio (3.93) than 67.91% of its industry peers.
A Quick Ratio of 2.88 indicates that AORT has no problem at all paying its short term obligations.
AORT has a Quick ratio of 2.88. This is in the better half of the industry: AORT outperforms 64.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -85.71% in the last year.
Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 9.81% in the last year.
AORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.06% yearly.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.17% yearly.
Based on estimates for the next years, AORT will show a quite strong growth in Revenue. The Revenue will grow by 11.94% on average per year.
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AORT is valuated quite expensively with a Price/Forward Earnings ratio of 96.55.
66.31% of the companies in the same industry are more expensive than AORT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (23.56), we can say AORT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 96.55 |
4.2 Price Multiples
66.84% of the companies in the same industry are more expensive than AORT, based on the Enterprise Value to EBITDA ratio.
AORT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AORT is cheaper than 68.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 120.27 | ||
| EV/EBITDA | 49.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 53.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.22%
EPS Next 3Y53.35%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:AORT (12/9/2025, 9:45:35 AM)
44.43
+0.36 (+0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.11%
Inst Owner ChangeN/A
Ins Owners4.19%
Ins Owner Change-6.39%
Market Cap2.10B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (18.73%)
Short Float %2.93%
Short Ratio3.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)14.27%
PT rev (3m)21.97%
EPS NQ rev (1m)22.44%
EPS NQ rev (3m)-8.95%
EPS NY rev (1m)86.52%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)0.93%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 96.55 | ||
| P/S | 4.98 | ||
| P/FCF | 120.27 | ||
| P/OCF | 69.1 | ||
| P/B | 4.8 | ||
| P/tB | 75.55 | ||
| EV/EBITDA | 49.36 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.46
Fwd EY1.04%
FCF(TTM)0.37
FCFY0.83%
OCF(TTM)0.64
OCFY1.45%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 3.83 |
F-Score5
WACC8.44%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year115.81%
EBIT Next 3Y44.55%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.